- Home
- INM vs CHNR Comparison
INM vs CHNR Comparison
Compare INM & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- CHNR
- Stock Information
- Founded
- INM 1981
- CHNR N/A
- Country
- INM Canada
- CHNR China
- Employees
- INM N/A
- CHNR N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- INM Health Care
- CHNR Basic Materials
- Exchange
- INM Nasdaq
- CHNR Nasdaq
- Market Cap
- INM 5.0M
- CHNR 5.3M
- IPO Year
- INM N/A
- CHNR 1995
- Fundamental
- Price
- INM $2.07
- CHNR $6.38
- Analyst Decision
- INM
- CHNR
- Analyst Count
- INM 0
- CHNR 0
- Target Price
- INM N/A
- CHNR N/A
- AVG Volume (30 Days)
- INM 116.2K
- CHNR 992.5K
- Earning Date
- INM 11-13-2025
- CHNR 11-11-2025
- Dividend Yield
- INM N/A
- CHNR N/A
- EPS Growth
- INM N/A
- CHNR N/A
- EPS
- INM N/A
- CHNR N/A
- Revenue
- INM $4,942,633.00
- CHNR N/A
- Revenue This Year
- INM N/A
- CHNR N/A
- Revenue Next Year
- INM N/A
- CHNR N/A
- P/E Ratio
- INM N/A
- CHNR N/A
- Revenue Growth
- INM 7.50
- CHNR N/A
- 52 Week Low
- INM $1.72
- CHNR $3.16
- 52 Week High
- INM $8.27
- CHNR $8.20
- Technical
- Relative Strength Index (RSI)
- INM 42.37
- CHNR 60.48
- Support Level
- INM $2.04
- CHNR $5.77
- Resistance Level
- INM $2.26
- CHNR $6.43
- Average True Range (ATR)
- INM 0.14
- CHNR 0.80
- MACD
- INM -0.01
- CHNR -0.00
- Stochastic Oscillator
- INM 10.44
- CHNR 46.47
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.